GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Futura Medical FUM.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.22p

+3.35%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in GBP, from our data supplier.

FY2024

Revenue

£13.9m

FY2016FY2024

Net income

£1.3m

FY2016FY2024

Free cash flow

−£1.3m

FY2016FY2024

Shareholders' equity

£9.0m

FY2016FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue£13.9m£3.1m———£31,778—£362,727£170,362
Research and development£1.7m£2.0m£4.1m£3.8m£1.9m£10.1m£6.0m£4.1m£3.5m
Operating income£1.2m−£7.0m−£6.9m−£5.9m−£2.9m−£11.2m−£7.3m−£4.9m−£4.6m
Net income£1.3m−£6.5m−£5.8m−£5.0m−£2.4m−£8.9m−£5.9m−£3.9m−£3.7m
Diluted earnings per share0.00-0.02-0.02-0.02-0.01-0.04-0.03-0.03-0.03

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets£13.6m£11.8m£6.5m£11.8m£1.6m£4.9m£10.9m£9.6m£13.4m
Cash and short-term investments£6.6m£7.7m£4.0m£10.4m£1.0m£2.5m£9.2m£8.4m£12.4m
Total liabilities£4.6m£6.3m£1.8m£2.1m£766,525£4.8m£2.0m£499,141£855,177
Debt——£432,151——£218,222———
Shareholders' equity£9.0m£5.5m£4.7m£9.7m£853,540£53,652£8.9m£9.1m£12.6m
Shares outstanding291m292m288m287m246m205m205m132m121m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations£438,411£570,253−£5.8m−£3.9m−£4.5m−£6.7m−£4.7m−£4.2m−£3.3m
Capital spending−£1.7m−£1.5m−£740,697−£419,722−£8,371−£32,736−£4,510−£55,594−£7,483
Free cash flow−£1.3m−£935,597−£6.5m−£4.3m−£4.6m−£6.7m−£4.7m−£4.2m−£3.3m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Revenue£1.6m£695,506£1.0m£6.9m£7.0m£1.4m£1.7m—
Operating income−£1.3m£1.1m−£6.7m£296,593£819,702−£5.0m−£2.0m−£4.0m
Net income−£1.2m−£2.5m−£6.6m£291,369£1.0m−£4.8m−£1.8m−£3.3m
Diluted earnings per share-0.00-0.00-0.010.000.00-0.02-0.01-0.01
Cash from operations−£2.0m−£2.0m−£2.0m£3.0m−£3.0m£1.0m—−£2.0m
Capital spending—————−£1.0m——
Free cash flow—————£0——
Total assets£4.2m£5.2m£5.5m£13.6m£9.5m£11.8m£10.2m£6.5m
Cash and short-term investments£1.2m£3.4m£3.7m£6.6m£3.9m£7.7m£7.8m£4.0m
Debt——————£644,110£432,151
Shareholders' equity£2.0m£2.8m£3.0m£9.0m£7.8m£5.5m£8.0m£4.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue——50.0%
Operating income-6.3%14.1%-0.8%
Net income15.8%30.4%6.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-28.7%———
Net margin-49.8%———

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.722.6-3.6-8.0-7.2-4.9-1.0-0.3-0.9-1.7
Price to sales3.82.17.6———282.5—10.237.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.